A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients
about
Passage of parasites across the blood-brain barrierThe role of cytokines in the pathogenesis and staging of Trypanosoma brucei rhodesiense sleeping sicknessOverview of the Diagnostic Methods Used in the Field for Human African Trypanosomiasis: What Could Change in the Next Years?Identification of stage biomarkers for human African trypanosomiasis.Actigraphy in human African trypanosomiasis as a tool for objective clinical evaluation and monitoring: a pilot studyCerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness.Blood glutathione S-transferase-π as a time indicator of stroke onsetUnravelling human trypanotolerance: IL8 is associated with infection control whereas IL10 and TNFα are associated with subsequent disease developmentStage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response.Neopterin is a cerebrospinal fluid marker for treatment outcome evaluation in patients affected by Trypanosoma brucei gambiense sleeping sickness.Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasisIncreased CXC ligand 10 levels and gene expression in type 1 leprosy reactionsInterleukin (IL)-6 and IL-10 Are Up Regulated in Late Stage Trypanosoma brucei rhodesiense Sleeping Sickness.Towards Point-of-Care Diagnostic and Staging Tools for Human African Trypanosomiaisis.CombiROC: an interactive web tool for selecting accurate marker combinations of omics data.H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury.New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patientsEmerging trends in the diagnosis of human African Trypanosomiasis.Human African trypanosomiasis in endemic populations and travellers.Proteomics: a new way to improve human African trypanosomiasis diagnosis?Iron Homeostasis and Trypanosoma brucei Associated Immunopathogenicity Development: A Battle/Quest for Iron.IL-9 and Th9 in parasite immunity.Plasma neuronal specific enolase: a potential stage diagnostic marker in human African trypanosomiasis.Expression of interferon-inducible chemokines and sleep/wake changes during early encephalitis in experimental African trypanosomiasis.IL-6 is upregulated in late-stage disease in monkeys experimentally infected with Trypanosoma brucei rhodesiense.Metabolic Profiling of Central Nervous System Disease in Trypanosoma brucei rhodesiense infection.Novel biomarkers for late-stage human African trypanosomiasis--the search goes on.Sleep and rhythm changes at the time of Trypanosoma brucei invasion of the brain parenchyma in the rat.The challenging problem of disease staging in human African trypanosomiasis (sleeping sickness): a new approach to a circular question.Neural Damage in Experimental Trypanosoma brucei gambiense Infection: Hypothalamic Peptidergic Sleep and Wake-Regulatory Neurons.New insights in staging and chemotherapy of African trypanosomiasis and possible contribution of medicinal plants.Mortality trends and risk factors in advanced stage-2 Human African Trypanosomiasis: A critical appraisal of 23 years of experience in the Democratic Republic of Congo.
P2860
Q24632132-26D26736-8EC3-451A-BBF4-AABE38A2668DQ26775041-F348A41B-8E8F-47C0-B47F-2A6D4C9787F4Q26778571-51AE2A66-AE02-4D08-BFCD-76C29AE1BAE5Q33880764-465BE0B1-04D7-48E7-8AC2-03FD95682BF9Q34163935-1BB0B0A5-858F-491A-854F-A795409A610CQ34345396-9C3B4D75-CFAA-4D04-9E85-888D60A1A10EQ34426843-0FF8B075-C011-42FD-B739-9B485A9F068FQ34466454-D614E0F3-ECA8-4C6A-A89C-B74BF5D05160Q34474577-27C40BE2-D2BD-42EB-B267-9B104574034CQ34613654-A14314AD-4BD4-4FA7-8A9F-B7C8D381791AQ35006575-1436453F-B82C-4E98-B596-B2CD07B6B546Q35066443-1B7F14CC-A437-4D17-B664-3634CFB9E684Q35668603-3C7D94E2-40CC-41CB-BF89-25479DBECC7CQ35876057-DA62DD74-2CE0-464D-9FDF-9CC46D97BCEFQ36327857-3E1F85D7-08F8-4943-BD1C-B562DF84D9F7Q36349690-74C9B0B4-C841-4F11-884A-0CA5AAC7CBF9Q36578354-76BFB612-6BD4-4FC9-AEFA-A5E0884B4BA3Q37728108-76A9A734-77AB-4944-B323-024969BF660FQ37929054-49803198-53E9-4408-8193-DE8AC793F964Q38115332-E122F134-4F77-4443-92B1-B36994E29268Q38532068-DD88FD58-FDD0-4110-AF5F-5BBEA4DB4188Q38789172-197F0B39-5521-4837-BA3C-768D59F6296BQ38862534-78E0D209-F238-43BE-B056-169418BE8AC3Q40087943-6E2C46D2-629D-4EC8-A9DC-0B75509851B5Q41901235-01165719-0138-48DD-96A1-545E58866B6AQ41996448-1C6201F5-84B1-4B73-9482-866A4EAF3811Q42767716-7A08D41F-AF3E-4CEC-A66B-5046A0541F8EQ44588565-2365D7BD-B6E4-4A21-B9BA-C9BC40649270Q46819563-AC91770E-581F-492E-9035-1EC9AA4FB77AQ51740583-16C02B8B-4F1C-404E-B53D-18A4CE2318D6Q53906272-351BF597-ACDD-49BC-A336-D7802B6F3CCAQ55322154-8113EB1D-7862-4438-A161-AB78DA7DB7EC
P2860
A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
A combined CXCL10, CXCL8 and H ...... rican trypanosomiasis patients
@ast
A combined CXCL10, CXCL8 and H ...... rican trypanosomiasis patients
@en
type
label
A combined CXCL10, CXCL8 and H ...... rican trypanosomiasis patients
@ast
A combined CXCL10, CXCL8 and H ...... rican trypanosomiasis patients
@en
prefLabel
A combined CXCL10, CXCL8 and H ...... rican trypanosomiasis patients
@ast
A combined CXCL10, CXCL8 and H ...... rican trypanosomiasis patients
@en
P2093
P2860
P50
P1476
A combined CXCL10, CXCL8 and H ...... rican trypanosomiasis patients
@en
P2093
Alexandre Hainard
Catherine Fouda
Dieudonné Mumba Ngoyi
Jean-Charles Sanchez
John Charles Enyaru
Joseph Mathu Ndung'u
Natacha Turck
P2860
P356
10.1371/JOURNAL.PNTD.0000459
P407
P577
2009-06-16T00:00:00Z